Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1427.50
-11.25 (-0.78%) Cipla informs about press release
Date: 24-05-2021Cipla has informed that it has enclosed press release dated 24th May 2021, titled ‘Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India’.
The above information is a part of company’s filings submitted to BSE.